Overview
Sponsor-declared trial summary
Moderately to Severely Active Ulcerative Colitis
To assess the improvement in bowel urgency severity at Week 12.
Key facts
- Sponsor
- Eli Lilly & Co.
- Participant type
- Patients
- Age range
- 18-64 years, 65+ years
- Gender
- Male and Female
- Therapeutic area
- Diseases [C] - Digestive System Diseases [C06]
- Trial duration
- 6 Sep 2023 → 27 Apr 2026
- Decision date (initial)
- 2023-07-24
- Transition trial
- No
- Low-intervention
- No
- Rare-disease indication
- No
- Vulnerable population
- Yes
External identifiers
- EU CT number
- 2022-502393-16-00
- WHO UTN
- U1111-1285-7055
- ClinicalTrials.gov
- NCT05767021
Trial design
CTIS Part I — objectives, methods, condition coding
Main objective
Scope: Therapy, Safety, Efficacy, Pharmacokinetic
To assess the improvement in bowel urgency severity at Week 12.
Conditions and MedDRA coding
Moderately to Severely Active Ulcerative Colitis
Eligibility criteria
Principal inclusion / exclusion criteria as submitted by sponsor
Inclusion criteria 4
- Have an established diagnosis of UC for ≥3 months
- Have confirmed diagnosis of moderately for severely active UC
- Have current bowel urgency
- Have demonstrated an inadequate response to, a loss of response to, or an intolerance to conventional or to biologic/Janus Kinase (JAK) inhibitor/sphingosine-1-phosphate (S1P) receptor modulator therapy for UC
Exclusion criteria 7
- Have Crohn's disease (CD)
- Have inflammatory bowel disease-unclassified, formerly known as indeterminate colitis, or
- Have ulcerative proctitis, disease limited to the rectum, that is, distal to the recto-sigmoid junction, which lies approximately 10 to 15 centimeter (cm) from anal verge
- Have an inherited immunodeficiency syndrome or a monogenic cause of UC-like colonic inflammation
- Have any history or current evidence of cancer of the gastrointestinal tract
- Have active tuberculosis
- Have HIV infection
Endpoints
Primary and secondary outcome measures (English text)
Primary endpoints 1
- Change from baseline in bowel urgency severity (UNRS) score at Week 12.
Investigational products
Investigational medicinal products (IMPs), comparators, placebo, auxiliary
Test 2
PRD10082863 · Product
- Active substance
- Mirikizumab
- Pharmaceutical form
- SOLUTION FOR INJECTION
- Route of administration
- SOLUTION FOR INJECTION OR INFUSION
- Max daily dose
- 0 mg milligram(s)
- Max total dose
- 0 mg milligram(s)
- Max treatment duration
- 1 Week(s)
- Authorisation status
- Not Authorised
- MA holder
- ELI LILLY AND COMPANY LIMITED
- Paediatric formulation
- No
- Orphan designation
- No
PRD10082852 · Product
- Active substance
- Mirikizumab
- Pharmaceutical form
- SOLUTION FOR INJECTION
- Route of administration
- SOLUTION FOR INJECTION OR INFUSION
- Max daily dose
- 0 mg milligram(s)
- Max total dose
- 0 mg milligram(s)
- Max treatment duration
- 1 Week(s)
- Authorisation status
- Not Authorised
- MA holder
- ELI LILLY AND COMPANY LIMITED
- Paediatric formulation
- No
- Orphan designation
- No
Sponsors and contacts
Sponsor organisations, regulatory contacts, third parties
Eli Lilly & Co.
- Sponsor organisation
- Eli Lilly & Co.
- Address
- 1 Lilly Corporate Center
- City
- Indianapolis
- Postcode
- 46285-0001
- Country
- United States
Scientific contact point
- Organisation
- Eli Lilly & Co.
- Contact name
- Lilly Clinical Trials information desk
Public contact point
- Organisation
- Eli Lilly & Co.
- Contact name
- Lilly Clinical Trials information desk
Third parties 7
| Organisation | City, country | Duties |
|---|---|---|
| Acelabio (US) Inc. ORG-100045270
|
San Diego, United States | Other |
| Cleveland Clinic Foundation ORG-100028017
|
Cleveland, United States | Other |
| Icon (Lr) Limited ORG-100042612
|
Dublin 18, Ireland | Laboratory analysis |
| Bioagilytix Labs LLC ORG-100013030
|
Durham, United States | Other |
| Greenphire LLC ORG-100041621
|
King Of Prussia, United States | Other |
| Iqvia Rds Inc. ORG-100043858
|
Durham, United States | On site monitoring, Code 10, Code 11, Code 12, Code 13, Other, Code 2, Code 5, Data management, Code 9 |
| RWS Life Sciences Inc. ORG-100042348
|
East Hartford, United States | Other, Data management |
Locations
9 EU/EEA countries · 64 investigational sites
By country
| Country | MS status | Planned subjects | Sites |
|---|---|---|---|
| Austria | Ended | 17 | 4 |
| Belgium | Ended | 3 | 2 |
| Czechia | Ended | 10 | 6 |
| France | Ended | 15 | 13 |
| Germany | Ended | 4 | 5 |
| Hungary | Ended | 8 | 8 |
| Italy | Ended | 12 | 7 |
| Poland | Ended | 40 | 15 |
| Slovakia | Ended | 7 | 4 |
| Rest of world
Canada, United Kingdom, United States
|
— | 57 | — |
Investigational sites
Country notifications
Trial-start, recruitment-start, end and early-termination notifications submitted per Member State
| Country | Trial start | Trial end | Recruitment start | Recruitment end | Early termination |
|---|---|---|---|---|---|
| Belgium | 2024-03-11 | 2024-04-17 | 2024-03-14 | 2024-04-17 | |
| Czechia | 2023-09-06 | 2025-05-20 | 2023-09-06 | 2024-05-16 | |
| France | 2023-09-26 | 2026-04-27 | 2023-11-06 | 2024-05-16 | |
| Germany | 2023-12-18 | ||||
| Hungary | 2023-09-11 | 2026-04-27 | 2023-09-11 | 2024-05-16 | |
| Italy | 2023-10-25 | 2025-06-23 | 2023-11-28 | 2024-05-16 | |
| Poland | 2023-09-11 | 2025-08-08 | 2023-09-19 | 2023-12-14 | |
| Slovakia | 2023-09-13 | 2026-02-24 | 2023-09-27 | 2024-05-16 |
Results and documents
Annex IV summary of results, Annex V layperson summary, and all documents registered in CTIS for this trial
Documents 426 files
Public protocol annexes, IB summaries, regulatory submissions and post-authorisation documents registered in CTIS.
| Type | Title | Version |
|---|---|---|
| Protocol (for publication) | D1_Collection of Race and Ethnicity Justification_2022-502393-16 | 1.0 |
| Protocol (for publication) | D1_Protocol_2022-502393-16_Redacted | Amend A |
| Protocol (for publication) | D4_Patient Facing Material_Abdominal Pain eCOA_UC_AT-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Abdominal Pain eCOA_UC_BE-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Abdominal Pain eCOA_UC_BE-NL_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Abdominal Pain eCOA_UC_DE-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Abdominal Pain eCOA_UC_FR-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Abdominal Pain eCOA_UC_HU-HU_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Abdominal Pain eCOA_UC_IT-IT_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Abdominal Pain eCOA_UC_SK-SK_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Absorbent Product Use_eCOA_AT-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Absorbent Product Use_eCOA_BE-FR_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Absorbent Product Use_eCOA_BE-NL_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Absorbent Product Use_eCOA_DE-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Absorbent Product Use_eCOA_EN-US_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Absorbent Product Use_eCOA_FR-FR_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Absorbent Product Use_eCOA_HU-HU_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Absorbent Product Use_eCOA_IT-IT_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Absorbent Product Use_eCOA_SK-SK_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Bowel Frequency_eCOA_AT-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Bowel Frequency_eCOA_BE-FR_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Bowel Frequency_eCOA_BE-NL_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Bowel Frequency_eCOA_DE-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Bowel Frequency_eCOA_FR-FR_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Bowel Frequency_eCOA_HU-HU_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Bowel Frequency_eCOA_IT-IT_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Bowel Frequency_eCOA_SK-SK_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Daily Diary_eCOA_EN-US_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_DDT_eCOA_AT-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_DDT_eCOA_BE-FR_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_DDT_eCOA_BE-NL_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_DDT_eCOA_DE-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_DDT_eCOA_FR-FR_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_DDT_eCOA_HU-HU_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_DDT_eCOA_IT-IT_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_DDT_eCOA_SK-SK_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Fatigue_eCOA_AT-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Fatigue_eCOA_BE-FR_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_Fatigue_eCOA_BE-NL_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_Fatigue_eCOA_DE-DE_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_Fatigue_eCOA_FR-FR_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_Fatigue_eCOA_HU-HU_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_Fatigue_eCOA_IT-IT_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_Fatigue_eCOA_SK-SK_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_GAD-7_eCOA_AT-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_GAD-7_eCOA_BE-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_GAD-7_eCOA_BE-NL_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_GAD-7_eCOA_DE-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_GAD-7_eCOA_EN-US_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_GAD-7_eCOA_FR-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_GAD-7_eCOA_HU-HU_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_GAD-7_eCOA_IT-IT_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_GAD-7_eCOA_SK-SK_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_IBDQ_eCOA_AT-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_IBDQ_eCOA_BE-FR_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_IBDQ_eCOA_BE-NL_Redsan | 5 |
| Protocol (for publication) | D4_Patient Facing Material_IBDQ_eCOA_DE-DE_Redsan | 7 |
| Protocol (for publication) | D4_Patient Facing Material_IBDQ_eCOA_EN-US_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_IBDQ_eCOA_FR-FR_Redsan | 11 |
| Protocol (for publication) | D4_Patient Facing Material_IBDQ_eCOA_HU-HU_Redsan | 3 |
| Protocol (for publication) | D4_Patient Facing Material_IBDQ_eCOA_IT-IT_red-san | 9 |
| Protocol (for publication) | D4_Patient Facing Material_IBDQ_eCOA_SK-SK_red-san | 6 |
| Protocol (for publication) | D4_Patient Facing Material_NoStools_eCOA_AT-DE_san | 3 |
| Protocol (for publication) | D4_Patient Facing Material_NoStools_eCOA_BE-FR_san | 3 |
| Protocol (for publication) | D4_Patient Facing Material_NoStools_eCOA_BE-NL_san | 3 |
| Protocol (for publication) | D4_Patient Facing Material_NoStools_eCOA_DE-DE_san | 3 |
| Protocol (for publication) | D4_Patient Facing Material_NoStools_eCOA_EN-US_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_NoStools_eCOA_FR-FR_san | 3 |
| Protocol (for publication) | D4_Patient Facing Material_NoStools_eCOA_HU-HU_san | 3 |
| Protocol (for publication) | D4_Patient Facing Material_NoStools_eCOA_IT-IT_san | 3 |
| Protocol (for publication) | D4_Patient Facing Material_NoStools_eCOA_SK-SK_san | 3 |
| Protocol (for publication) | D4_Patient Facing Material_NS_eCOA_AT-DE_San | 1 |
| Protocol (for publication) | D4_Patient Facing Material_NS_eCOA_BE-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_NS_eCOA_BE-NL_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_NS_eCOA_DE-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_NS_eCOA_FR-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_NS_eCOA_HU-HU_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_NS_eCOA_IT-IT_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_NS_eCOA_SK-SK_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGI-C_eCOA_AT-DE_san | 1.1 |
| Protocol (for publication) | D4_Patient Facing Material_PGI-C_eCOA_BE-FR_san | 1.1 |
| Protocol (for publication) | D4_Patient Facing Material_PGI-C_eCOA_BE-NL_san | 1.1 |
| Protocol (for publication) | D4_Patient Facing Material_PGI-C_eCOA_DE-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGI-C_eCOA_EN-US_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGI-C_eCOA_FR-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGI-C_eCOA_HU-HU_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGI-C_eCOA_IT-IT_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGI-C_eCOA_SK-SK_san | 1.1 |
| Protocol (for publication) | D4_Patient Facing Material_PGR-S_UC_eCOA_AT-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGR-S_UC_eCOA_BE-FR_san | 1.1 |
| Protocol (for publication) | D4_Patient Facing Material_PGR-S_UC_eCOA_BE-NL_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGR-S_UC_eCOA_DE-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGR-S_UC_eCOA_FR-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGR-S_UC_eCOA_HU-HU_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGR-S_UC_eCOA_IT-IT_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_PGR-S_UC_eCOA_SK-SK_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_QIDS-SR16_eCOA_AT-DE_Redsan | 8 |
| Protocol (for publication) | D4_Patient Facing Material_QIDS-SR16_eCOA_BE-FR_red-san | 8 |
| Protocol (for publication) | D4_Patient Facing Material_QIDS-SR16_eCOA_BE-NL_Redsan | 8 |
| Protocol (for publication) | D4_Patient Facing Material_QIDS-SR16_eCOA_DE-DE_Redsan | 8 |
| Protocol (for publication) | D4_Patient Facing Material_QIDS-SR16_eCOA_EN-US_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_QIDS-SR16_eCOA_FR-FR_Redsan | 8 |
| Protocol (for publication) | D4_Patient Facing Material_QIDS-SR16_eCOA_HU-HU_Redsan | 8 |
| Protocol (for publication) | D4_Patient Facing Material_QIDS-SR16_eCOA_IT-IT_red-san | 8 |
| Protocol (for publication) | D4_Patient Facing Material_QIDS-SR16_eCOA_SK-SK_red-san | 8 |
| Protocol (for publication) | D4_Patient Facing Material_RB_eCOA_AT-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_RB_eCOA_BE-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_RB_eCOA_BE-NL_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_RB_eCOA_DE-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_RB_eCOA_FR-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_RB_eCOA_HU-HU_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_RB_eCOA_IT-IT_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_RB_eCOA_SK-SK_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Female_eCOA_AT-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Female_eCOA_BE-FR_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Female_eCOA_BE-NL_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Female_eCOA_DE-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Female_eCOA_EN-US_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Female_eCOA_FR-FR_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Female_eCOA_HU-HU_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Female_eCOA_IT-IT_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Female_eCOA_SK-SK_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Male_eCOA_AT-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Male_eCOA_BE-FR_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Male_eCOA_BE-NL_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Male_eCOA_DE-DE_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Male_eCOA_EN-US_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Male_eCOA_FR-FR_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Male_eCOA_HU-HU_Redsan | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Male_eCOA_IT-IT_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SAA_Male_eCOA_SK-SK_red-san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SConsistency_eCOA_AT-DE_Redsan | 2 |
| Protocol (for publication) | D4_Patient Facing Material_SConsistency_eCOA_BE-FR_red-san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_SConsistency_eCOA_BE-NL_Redsan | 2 |
| Protocol (for publication) | D4_Patient Facing Material_SConsistency_eCOA_DE-DE_Redsan | 2 |
| Protocol (for publication) | D4_Patient Facing Material_SConsistency_eCOA_FR-FR_Redsan | 2 |
| Protocol (for publication) | D4_Patient Facing Material_SConsistency_eCOA_HU-HU_Redsan | 2 |
| Protocol (for publication) | D4_Patient Facing Material_SConsistency_eCOA_IT-IT_red-san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_SConsistency_eCOA_SK-SK_red-san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_SFrequency_eCOA_AT-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SFrequency_eCOA_BE-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SFrequency_eCOA_BE-NL_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SFrequency_eCOA_DE-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SFrequency_eCOA_FR-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SFrequency_eCOA_HU-HU_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SFrequency_eCOA_IT-IT_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_SFrequency_eCOA_SK-SK_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Stool_eCOA_AT-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Stool_eCOA_BE-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Stool_eCOA_BE-NL_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Stool_eCOA_DE-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Stool_eCOA_FR-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Stool_eCOA_HU-HU_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Stool_eCOA_IT-IT_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Stool_eCOA_SK-SK_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Urgency NRS_eCOA_AT-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Urgency NRS_eCOA_BE-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Urgency NRS_eCOA_BE-NL_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Urgency NRS_eCOA_DE-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Urgency NRS_eCOA_FR-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Urgency NRS_eCOA_HU-HU_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Urgency NRS_eCOA_IT-IT_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_Urgency NRS_eCOA_SK-SK_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WIS_eCOA_DE-DE_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WIS_eCOA_EN-US_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WIS_eCOA_FR-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WIS_eCOA_HU-HU_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WIS_eCOA_IT-IT_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WIS_eCOA_SK-SK_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WIS_eCOA-AT-DE_San | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WIS_eCOA-BE-FR_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WIS_eCOA-BE-NL_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WPAI-UC_eCOA_DE-DE_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_WPAI-UC_eCOA_EN-US_san | 1 |
| Protocol (for publication) | D4_Patient Facing Material_WPAI-UC_eCOA_FR-FR_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_WPAI-UC_eCOA_HU-HU_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_WPAI-UC_eCOA_IT-IT_san | 2 |
| Protocol (for publication) | D4_Patient Facing Material_WPAI-UC_eCOA_SK-SK_san | 2 |
| Protocol (for publication) | D4_Patient Facing Materials_WPAI-UC_eCOA_AT-DE_san | 2 |
| Protocol (for publication) | D4_Patient Facing Materials_WPAI-UC_eCOA_BE-FR_san | 2 |
| Protocol (for publication) | D4_Patient Facing Materials_WPAI-UC_eCOA_BE-NL_san | 2 |
| Protocol (for publication) | Instructions for PRO items_Adult_v1_eCOA Ready_German-DE_24Jan2023_san | 1 |
| Protocol (for publication) | Instructions for PRO items_Adult_v1_eCOA Ready_Italian-IT_24Jan2023_san | 1 |
| Recruitment arrangements (for publication) | K1_Digital Waiting Room Ad | 1 |
| Recruitment arrangements (for publication) | K1_Recruitment arrangements omission justification_Hungary_san | 1 |
| Recruitment arrangements (for publication) | K1_Recruitment arrangements_san | 2.0 |
| Recruitment arrangements (for publication) | K1_Recruitment arrangements_San | ITA |
| Recruitment arrangements (for publication) | K1_Recruitment arrangements_san | Final |
| Recruitment arrangements (for publication) | K1_Recruitment arrangements_TC_san | 2.0 |
| Recruitment arrangements (for publication) | K2_Digital Waiting Room Ad_San | V01 ITA(it |
| Recruitment arrangements (for publication) | K2_Dr-to-Patient Letter_San | V01 ITA(it |
| Recruitment arrangements (for publication) | K2_Patient Brochure_San | V01 ITA(it |
| Recruitment arrangements (for publication) | K2_Physician Referral Letter | 1 |
| Recruitment arrangements (for publication) | K2_Recruitment material URGE Digital Waiting Room Ad_san | V01SVK(sk) |
| Recruitment arrangements (for publication) | K2_Recruitment material URGE Dr to Patient Letter_san | 1SVK(sk)01 |
| Recruitment arrangements (for publication) | K2_Recruitment material URGE Patient Brochure_san | V01SVK(sk) |
| Recruitment arrangements (for publication) | K2_Recruitment material_Digital Waiting Room Ad_san | V01POL(pl) |
| Recruitment arrangements (for publication) | K2_Recruitment material_Doctor to Patient Letter_san | V01POL(pl) |
| Recruitment arrangements (for publication) | K2_Recruitment material_Patient Brochure_san | V01POL(pl |
| Recruitment arrangements (for publication) | K3_Patient Brochure | 1 |
| Recruitment arrangements (for publication) | Recruitment and Consent | 2 |
| Recruitment arrangements (for publication) | Recruitment and ICF Procedure_cs_san | 1 |
| Recruitment arrangements (for publication) | Recruitment Tools_Digital Waiting Room Ad | V01FRAfr |
| Recruitment arrangements (for publication) | Recruitment Tools_Dr-to-Patient Letter | V01FRAfr01 |
| Recruitment arrangements (for publication) | Recruitment Tools_Patient Brochure | V01FRAfr |
| Recruitment arrangements (for publication) | Recruitment Tools_Physician Referral Brochure | V01FRAfr |
| Recruitment arrangements (for publication) | Recruitment Tools_Physician Referral Letter A4 | V01FRAfr01 |
| Subject information and informed consent form (for publication) | Abdominal Pain_UC_eCOA _cs_san | 1 |
| Subject information and informed consent form (for publication) | Absorbent Product Use for Bowel Urgency_v1_eCOA Ready_Czech-CZ_24Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | Bowel Urgency Frequency_v1_eCOA Ready_Czech-CZ_07Dec2022_san | 1 |
| Subject information and informed consent form (for publication) | ClinCard Cardholder FAQ_cs_san | CZE v 10.0 |
| Subject information and informed consent form (for publication) | ClinCard Cardholder Msg Templates_cs_san | CZE v 10.0 |
| Subject information and informed consent form (for publication) | ClinCard_Card_cs_san | CZE v 10.0 |
| Subject information and informed consent form (for publication) | ClinCard_Fee_Schedule_cs_san | CZE v 10.0 |
| Subject information and informed consent form (for publication) | ClinCard_Generic_Image_cs_san | CZE v 10.0 |
| Subject information and informed consent form (for publication) | ConneX Travel Contact Card_cs_san | CZE v 10.0 |
| Subject information and informed consent form (for publication) | ConneX Travel Reference Guide for Participants_cs_san | CZE v 10.0 |
| Subject information and informed consent form (for publication) | Cont Access ICF_cs_red and san | V2.0CZE1.0 |
| Subject information and informed consent form (for publication) | Cover Lettre _SM_12Oct2023_Czech Republic | 2 |
| Subject information and informed consent form (for publication) | Czech Republic PFS QR video link_cs_san | CZE |
| Subject information and informed consent form (for publication) | Defecation Deferral Time_v1_eCOA Ready_Czech-CZ_9Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | Definition of Stool_v1_eCOA Ready_Czech-CZ_29Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | Digital Waiting Room Ad_cs_san | V01CZE(cs) |
| Subject information and informed consent form (for publication) | Dr to Patient Letter_cs_san | 01CZEcs01 |
| Subject information and informed consent form (for publication) | eDiary and ePRO Overview Storyboard_cs_san | V01CZE(cs) |
| Subject information and informed consent form (for publication) | Fatigue_v2_eCOA Ready_Czech-CZ_29Jan2023_san | 2 |
| Subject information and informed consent form (for publication) | GAD-7_v1_eCOA Ready_Czech-CZ_26Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | HAQ-DI_ePRO | 1.0ces-CZ1 |
| Subject information and informed consent form (for publication) | IBDQ_v2_eCOA Ready_Czech-CZ_03Feb2023_san | 2 |
| Subject information and informed consent form (for publication) | Informed Consent Form_Continued Access_Red | V1.0FRA2.0 |
| Subject information and informed consent form (for publication) | Informed Consent Form_Main _Add n1_San | 1.0FRA1.0 |
| Subject information and informed consent form (for publication) | Informed Consent Form_Main_Red | V2.0FRA1.0 |
| Subject information and informed consent form (for publication) | Informed Consent Form_PP | V1.0FRA1.0 |
| Subject information and informed consent form (for publication) | Instructions for PRO items_Adult_v1_eCOA Ready_Czech-CZ_24Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | L1_Main ICF_SoC_cs_san | V2.0CZE1.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF Continued Access_red-san | V2.0SVK1.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF Continued Access_TC_red-san | V2.0SVK1.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF Main Data Privacy Addendum_red-san | V1.0SVK1.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF Main_hu_Redacted | 4 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF Main_hu_TC | 4 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF Main_red-san | V2.0SVK1.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF Main_TC_red-san | V2.0SVK1.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF Pregnant Partner_san | V1.0SVK2.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF Pregnant Partner_TC_san | V1.0SVK2.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF SoC_IT_San | V1.0ITA1.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF SOC_san | V1.0SVK1.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF_ Main_redacted | V2.0POL2.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF_Continued Access Addendum_Red-San | V2.0ITA1.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF_Continued Access_redacted | V2.0POL2.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF_Main Adult_Red-San | V2.0ITA2.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF_Pregnant Participant_San | V1.0ITA2.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF_Pregnant Partner_redacted | 1.0POL1.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF_Pregnant Partner_San | V2.0ITA2.0 |
| Subject information and informed consent form (for publication) | L1_SIS and ICF_SoC ICF_PL_san | v1.0POL2.0 |
| Subject information and informed consent form (for publication) | L1_SIS and Summary of Changes_ICF_hu_san | V1.0HUN2.0 |
| Subject information and informed consent form (for publication) | L10_Hungary PFS QR video link_en | 1 |
| Subject information and informed consent form (for publication) | L11_How to Inject Video_Script_hu | 1 |
| Subject information and informed consent form (for publication) | L12_How to Inject Video_OnScreen_hu | 1 |
| Subject information and informed consent form (for publication) | L13_ePFS CT IFU_hu | 1.0 |
| Subject information and informed consent form (for publication) | L14_ClinCard_Card_Carrier_hu_Redacted | 1 |
| Subject information and informed consent form (for publication) | L15_ClinCard Cardholder FAQ_hu | 10.0 |
| Subject information and informed consent form (for publication) | L16_ClinCard Cardholder Msg Templates_hu | 10.0 |
| Subject information and informed consent form (for publication) | L17_ClinCard_Fee_Schedule_hu | 1 |
| Subject information and informed consent form (for publication) | L18_ClinCard_Generic_Image | 10.0 |
| Subject information and informed consent form (for publication) | L19_ConneX Travel Contact Card_hu_Redacted | 10.0 |
| Subject information and informed consent form (for publication) | L2_GP Letter_Red-San | V1.0 ITA |
| Subject information and informed consent form (for publication) | L2_Instructions for use prefilled syringes_Italian_San | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Abdominal Pain_eCOA_UC_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Absorbent Product Use_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Bowel Frequency_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_ClinCard FAQ_san | 10.0 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_ClinCard Image_san | 10.0 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_ClinCard Msg Templates_san | 10.0 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_ClinCard_Card_Carrier_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_ClinCard_Fee Schedule_san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_ConneX Travel Contact Card_red-san | 10.0 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_ConneX Travel Ref Guide_red-san | 10.0 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_DDT_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Fatigue_eCOA_SK-SK_red-san | 2 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_GAD-7_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_IBDQ_eCOA_SK-SK_red-san | 6 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Instructions for use_san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Instructions_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_NoStools_eCOA_SK-SK_red-san | 3 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_NS_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Participant Brochure_red-san | 1.0 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Participant ID Card_san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_PFS QR video link_san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_PGI-C_eCOA_SK-SK_red-san | 1.1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_PGR-S_UC_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_QIDS-SR16_eCOA_SK-SK_red-san | TS8.0 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_RB_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_SAA_Female_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_SAA_Male_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_SConsistency_eCOA_SK-SK_red-san | 2 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_SFrequency_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Stool_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Study Drug Self-Administration Log_san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Study Drug Self-Administration Training Log_san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_Urgency NRS_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_WIS_eCOA_SK-SK_red-san | 1 |
| Subject information and informed consent form (for publication) | L2_Other subject information material_WPAI-UC_eCOA_SK-SK_red-san | 2.0 |
| Subject information and informed consent form (for publication) | L2_Participant Guide_Italian_Red-San | 1.0 |
| Subject information and informed consent form (for publication) | L2_Participant ID Card_Italian_San | V01 ITA |
| Subject information and informed consent form (for publication) | L2_Patient Study Drug Self-Administration Log_Italian_San | 1 |
| Subject information and informed consent form (for publication) | L2_Patient Study Drug Self-Administration Training Log_Italian_San | 1 |
| Subject information and informed consent form (for publication) | L2_Patient__Greenphire_ClinCard Card Carrier_redacted | 10.0 |
| Subject information and informed consent form (for publication) | L2_Patient__Greenphire_ClinCard Cardholder FAQ_san | 10.0 |
| Subject information and informed consent form (for publication) | L2_Patient__Greenphire_ClinCard Cardholder Msg Template_san | 10.0 |
| Subject information and informed consent form (for publication) | L2_Patient__Greenphire_ClinCard Fee Schedule_san | 10.0 |
| Subject information and informed consent form (for publication) | L2_Patient__Greenphire_ClinCard Generic Image_san | 10.0 |
| Subject information and informed consent form (for publication) | L2_Patient__Greenphire_ConneX Travel Contact Card_redacted | 10.0 |
| Subject information and informed consent form (for publication) | L2_Patient__Greenphire_ConneX Travel Contact Card_san | 10.0 |
| Subject information and informed consent form (for publication) | L2_Patient__Greenphire_ConneX Travel Reference Guide for participants_redacted | 10.0 |
| Subject information and informed consent form (for publication) | L2_Patient_eCOA Participant Guide_redacted | 1.0 |
| Subject information and informed consent form (for publication) | L2_Patient_eDiary and ePRO Overview Storyboard_san | V01POL(pl) |
| Subject information and informed consent form (for publication) | L2_Patient_ID Card_san | 01 |
| Subject information and informed consent form (for publication) | L2_Patient_IFU prefilled syringe_san | 1.0 |
| Subject information and informed consent form (for publication) | L2_Patient_Patient Study Guide_san | V01POL(pl) |
| Subject information and informed consent form (for publication) | L2_Patient_PFS How to Inject Video_san | 1.0 |
| Subject information and informed consent form (for publication) | L2_Patient_Stool Collection Guide Screening Period_san | V01POL(pl) |
| Subject information and informed consent form (for publication) | L2_Patient_Stool Collection Guide Study Treatment Period_san | V01POL(pl) |
| Subject information and informed consent form (for publication) | L2_Patient_Study Drug Self-Administration Log_san | 1 |
| Subject information and informed consent form (for publication) | L2_Patient_Study Drug Self-Administration Training Log_san | 1 |
| Subject information and informed consent form (for publication) | L2_PFS QR video link_Italian_San | NA |
| Subject information and informed consent form (for publication) | L2_SIS Mandatory Genetic_hu | 1 |
| Subject information and informed consent form (for publication) | L20_ConneX Travel Reference Guide_hu_Redacted | 10.0 |
| Subject information and informed consent form (for publication) | L21_I6T-MC-AMBZ_List of submitted documents_en | 2 |
| Subject information and informed consent form (for publication) | L21_I6T-MC-AMBZ_List of submitted documents_hu | 2 |
| Subject information and informed consent form (for publication) | L22_List of submitted documents_hu_en | 1 |
| Subject information and informed consent form (for publication) | L3_ICF Mandatory Genetic_hu | 1 |
| Subject information and informed consent form (for publication) | L3_Stool Collection Guide Screening Period | 1 |
| Subject information and informed consent form (for publication) | L4_SIS and ICF Continued Access_hu_Redacted | 2 |
| Subject information and informed consent form (for publication) | L4_Stool Collection Guide Study Treatment Period | 1 |
| Subject information and informed consent form (for publication) | L5_eDiary and ePRO Overview Storyboard | 1 |
| Subject information and informed consent form (for publication) | L5_SIS and ICF Pregnant Partner_hu_Redacted | 1 |
| Subject information and informed consent form (for publication) | L6_Participant ID Card_hu_Redacted | 1 |
| Subject information and informed consent form (for publication) | L6_Patient Study Guide | 1 |
| Subject information and informed consent form (for publication) | L7_ Participant Guide_hu | 1.0 |
| Subject information and informed consent form (for publication) | L7_Instructions for PRO items | 1 |
| Subject information and informed consent form (for publication) | L8_ Study Drug Self Administration Log_hu | 1 |
| Subject information and informed consent form (for publication) | L9_Study Drug Self Administration Training_hu | 1 |
| Subject information and informed consent form (for publication) | List of documents for Part II_cs | NA |
| Subject information and informed consent form (for publication) | Main GDPR ICF_cs_san | CZE1.0 |
| Subject information and informed consent form (for publication) | Main ICF_already included _cs_red and san | V2.0CZE1.0 |
| Subject information and informed consent form (for publication) | Main ICF_cs_red and san | V2.0CZE1.0 |
| Subject information and informed consent form (for publication) | Miri PFS How to Inject Video_2_cs_san | 1.0 |
| Subject information and informed consent form (for publication) | Miri PFS How to Inject Video_cs_san | 1.0 |
| Subject information and informed consent form (for publication) | Nocturnal Stools_v1_eCOA Ready_Czech-CZ_29Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | Normal no of stools_v3_eCOA Ready_Czech-CZ_07Dec2022_san | 3 |
| Subject information and informed consent form (for publication) | Participant Diary | 1.0CZE(cs) |
| Subject information and informed consent form (for publication) | Participant Guide_cs_san | 1.0 |
| Subject information and informed consent form (for publication) | Participant ID Card_cs_san | V01CZE(cs) |
| Subject information and informed consent form (for publication) | Patient Brochure_cs_san | V01CZE(cs) |
| Subject information and informed consent form (for publication) | Patient Study Drug Self Administration Log_cs_san | 1 |
| Subject information and informed consent form (for publication) | Patient Study Drug Self Administration Training Log_cs_san | 1 |
| Subject information and informed consent form (for publication) | Patient Study Guide_cs_san | V01CZE(cs) |
| Subject information and informed consent form (for publication) | Patient_ eCOA Guide | v1.0 |
| Subject information and informed consent form (for publication) | Patient_ GreenPhire Direct Deposit FAQ | v10.0 |
| Subject information and informed consent form (for publication) | Patient_ GreenPhire Direct Deposit msg templates | v10.0 |
| Subject information and informed consent form (for publication) | Patient_eDiary and ePRO Overview Storyboard | V01FRAfr |
| Subject information and informed consent form (for publication) | Patient_GreenPhire ConneX Contact Card_Red | v10.0 |
| Subject information and informed consent form (for publication) | Patient_GreenPhire ConneX Travel Guide_Red | v10.0 |
| Subject information and informed consent form (for publication) | Patient_ID Card | V01FRA(fr) |
| Subject information and informed consent form (for publication) | Patient_Instruction for use_Red | v1 |
| Subject information and informed consent form (for publication) | Patient_Instructionnal Video Link_Red | 1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Abdominal Pain | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Absorbent Product Use for Bowel Urgency | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Bowel Urgency Frequency | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Defecation Deferral Time | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Definition of Stool | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Fatigue | v2 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_GAD-7 | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_IBDQ | v11 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Instructions for PRO items | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Nocturnal Stools | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Normal no of stools | v3 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_PGI-C | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_PGR-S | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_QIDS-SR16 | TS8.0 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Rectal Bleeding | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Sexual Activity Avoidance_Female | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Sexual Activity Avoidance_Male | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Stool Consistency_ | v2 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Stool Frequency | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Urgency NRS | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_Wexner Incontinence Score | v1 |
| Subject information and informed consent form (for publication) | Patient_Questionnaire_WPAI-UC | v2.0 |
| Subject information and informed consent form (for publication) | Patient_Stool Collection Guide Screening Period | V01FRAfr |
| Subject information and informed consent form (for publication) | Patient_Stool Collection Guide Study Treatment Period | V01FRAfr |
| Subject information and informed consent form (for publication) | Patient_Study Drug Self-Administration Log_Red | v1 |
| Subject information and informed consent form (for publication) | Patient_Study Drug Self-Administration Training Log_Red | v1 |
| Subject information and informed consent form (for publication) | Patient_Study Guide | V01FRAfr |
| Subject information and informed consent form (for publication) | PGI-C_v1_eCOA Ready_Czech-CZ_26Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | PGR-S_UC_v1_eCOA Ready_Czech-CZ_06Feb2023_san | 1 |
| Subject information and informed consent form (for publication) | PP GDPR ICF_cs_san | CZE1.0 |
| Subject information and informed consent form (for publication) | PP ICF_cs_san | V1.0CZE1.0 |
| Subject information and informed consent form (for publication) | PROMIS_ePRO_cs | 1.1_4a |
| Subject information and informed consent form (for publication) | QIDS-SR16_TS8 0_eCOA Ready_Czech-CZ_26Jan2023_san | 8 |
| Subject information and informed consent form (for publication) | Rectal Bleeding_v1_eCOA Ready_Czech-CZ_29Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | Reimbursement and Reminder ICF_ cs_san | V1.0CZE1.0 |
| Subject information and informed consent form (for publication) | Sexual Activity Avoidance_Female_Version_v1_eCOA Ready_Czech-CZ_24Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | Sexual Activity Avoidance_Male_Version_v1_eCOA Ready_Czech-CZ_07Dec2022_san | 1 |
| Subject information and informed consent form (for publication) | SF36_ePRO_CZ | 1.1 |
| Subject information and informed consent form (for publication) | SGA_ePRO_cs | 03 |
| Subject information and informed consent form (for publication) | Skindex_ePRO_cs | 2.0_ces-CZ |
| Subject information and informed consent form (for publication) | Stool Collection Guide_ Study Treatment Period_cs_san | V01CZE(cs) |
| Subject information and informed consent form (for publication) | Stool Collection Guide_Screening Period_cs_san | V01CZE |
| Subject information and informed consent form (for publication) | Stool Consistency_v2_eCOA Ready_Czech-CZ_07Dec2022_san | 2 |
| Subject information and informed consent form (for publication) | Stool Frequency_v1_eCOA Ready_Czech-CZ_29Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | UC ePFS CT IFU_Trans_Paper_cs_san | 1 |
| Subject information and informed consent form (for publication) | Urgency_v1_eCOA Ready_Czech-CZ_29Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | Wexner Incontinence Score_v1_eCOA Ready_Czech-CZ_9Jan2023_san | 1 |
| Subject information and informed consent form (for publication) | WPAI-UC_v2 0_eCOA Ready_Paper_Czech CZ_26Jan2023_san | 2 |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_AT-DE_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_BE-DE_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_BE-FR_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_BE-NL_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_CZ_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_DE_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_EN_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_FR_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_HU_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_IT_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_PL_2022-502393-16_Redacted | A |
| Synopsis of the protocol (for publication) | D1_Protocol Synopsis_SK_2022-502393-16_Redacted | A |
Application history
22 submissions — initial application plus substantial / non-substantial modifications
| # | Type | Code | Submitted | Reference MS | Conclusion | Decision date |
|---|---|---|---|---|---|---|
| 1 | INITIAL | IN | 2023-03-24 | Slovakia | Acceptable 2023-07-17
|
2023-07-17 |
| 2 | NON SUBSTANTIAL MODIFICATION | NSM-2 | 2023-08-10 | Acceptable 2023-07-17
|
2023-08-10 | |
| 3 | SUBSTANTIAL MODIFICATION | SM-2 | 2023-10-25 | Slovakia | Acceptable 2024-01-10
|
2024-01-10 |
| 4 | SUBSTANTIAL MODIFICATION | SM-5 | 2024-04-25 | Slovakia | Acceptable 2024-07-01
|
2024-07-02 |
| 5 | NON SUBSTANTIAL MODIFICATION | NSM-11 | 2024-10-17 | Slovakia | Acceptable 2024-07-01
|
2024-10-17 |
| 6 | SUBSTANTIAL MODIFICATION | SM-7 | 2024-12-12 | Acceptable | 2025-01-09 | |
| 7 | SUBSTANTIAL MODIFICATION | SM-8 | 2024-12-12 | Acceptable | 2025-02-05 | |
| 8 | SUBSTANTIAL MODIFICATION | SM-11 | 2024-12-12 | Acceptable | 2025-03-13 | |
| 9 | SUBSTANTIAL MODIFICATION | SM-9 | 2024-12-13 | Acceptable | 2025-02-27 | |
| 10 | SUBSTANTIAL MODIFICATION | SM-10 | 2024-12-13 | Acceptable | 2025-03-27 | |
| 11 | SUBSTANTIAL MODIFICATION | SM-6 | 2024-12-17 | Slovakia | Acceptable | 2025-03-04 |
| 12 | NON SUBSTANTIAL MODIFICATION | NSM-12 | 2025-04-17 | Acceptable | 2025-04-17 | |
| 13 | NON SUBSTANTIAL MODIFICATION | NSM-13 | 2025-04-22 | Acceptable | 2025-04-22 | |
| 14 | NON SUBSTANTIAL MODIFICATION | NSM-14 | 2025-04-24 | Acceptable | 2025-04-24 | |
| 15 | NON SUBSTANTIAL MODIFICATION | NSM-15 | 2025-04-25 | Slovakia | Acceptable | 2025-04-25 |
| 16 | NON SUBSTANTIAL MODIFICATION | NSM-16 | 2025-05-07 | Acceptable | 2025-05-07 | |
| 17 | SUBSTANTIAL MODIFICATION | SM-12 | 2025-07-04 | Acceptable | 2025-07-17 | |
| 18 | NON SUBSTANTIAL MODIFICATION | NSM-17 | 2025-08-08 | Acceptable | 2025-08-08 | |
| 19 | NON SUBSTANTIAL MODIFICATION | NSM-18 | 2025-09-22 | Acceptable | 2025-09-22 | |
| 20 | NON SUBSTANTIAL MODIFICATION | NSM-19 | 2025-10-16 | Acceptable | 2025-10-16 | |
| 21 | NON SUBSTANTIAL MODIFICATION | NSM-20 | 2025-12-10 | Slovakia | Acceptable | 2025-12-10 |
| 22 | SUBSTANTIAL MODIFICATION | SM-14 | 2026-04-10 | Slovakia | Acceptable | 2026-05-26 |